[go: up one dir, main page]

HUP0002643A3 - Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) - Google Patents

Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Info

Publication number
HUP0002643A3
HUP0002643A3 HU0002643A HUP0002643A HUP0002643A3 HU P0002643 A3 HUP0002643 A3 HU P0002643A3 HU 0002643 A HU0002643 A HU 0002643A HU P0002643 A HUP0002643 A HU P0002643A HU P0002643 A3 HUP0002643 A3 HU P0002643A3
Authority
HU
Hungary
Prior art keywords
ssri
prevention
treatment
selective serotonin
uptake inhibitors
Prior art date
Application number
HU0002643A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HUP0002643A2 publication Critical patent/HUP0002643A2/hu
Publication of HUP0002643A3 publication Critical patent/HUP0002643A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0002643A 1997-07-14 1998-07-14 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) HUP0002643A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714841.5A GB9714841D0 (en) 1997-07-14 1997-07-14 Treatment method
PCT/GB1998/002073 WO1999003469A1 (en) 1997-07-14 1998-07-14 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Publications (2)

Publication Number Publication Date
HUP0002643A2 HUP0002643A2 (hu) 2001-10-28
HUP0002643A3 true HUP0002643A3 (en) 2001-11-28

Family

ID=10815849

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002643A HUP0002643A3 (en) 1997-07-14 1998-07-14 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)

Country Status (16)

Country Link
US (1) US6372763B1 (hu)
EP (1) EP0996445A1 (hu)
JP (1) JP2001510155A (hu)
KR (1) KR20010021796A (hu)
CN (1) CN1263465A (hu)
AU (1) AU739466B2 (hu)
BR (1) BR9811004A (hu)
CA (1) CA2296468A1 (hu)
GB (1) GB9714841D0 (hu)
HU (1) HUP0002643A3 (hu)
IL (1) IL133908A0 (hu)
NO (1) NO20000169L (hu)
NZ (1) NZ502201A (hu)
PL (1) PL337996A1 (hu)
TR (1) TR200000090T2 (hu)
WO (1) WO1999003469A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245782B1 (en) * 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
EP1522539B1 (en) 2001-07-31 2007-01-24 H. Lundbeck A/S Crystalline composition containing escitalopram
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
AU2003300264A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0768083B1 (en) * 1995-07-17 2003-03-26 Pfizer Inc. Sertraline for treating post myocardial infarction patients

Also Published As

Publication number Publication date
AU8349498A (en) 1999-02-10
TR200000090T2 (tr) 2000-09-21
EP0996445A1 (en) 2000-05-03
CN1263465A (zh) 2000-08-16
CA2296468A1 (en) 1999-01-28
BR9811004A (pt) 2000-09-19
KR20010021796A (ko) 2001-03-15
NZ502201A (en) 2001-12-21
HUP0002643A2 (hu) 2001-10-28
PL337996A1 (en) 2000-09-25
IL133908A0 (en) 2001-04-30
AU739466B2 (en) 2001-10-11
NO20000169D0 (no) 2000-01-13
WO1999003469A1 (en) 1999-01-28
JP2001510155A (ja) 2001-07-31
US6372763B1 (en) 2002-04-16
NO20000169L (no) 2000-01-13
GB9714841D0 (en) 1997-09-17

Similar Documents

Publication Publication Date Title
HUP0200495A3 (en) Method of treating eating disorders
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
PL320822A1 (en) Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds
AU2209697A (en) Fluorocarbons for diagnosis and treatment of articular disorders
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
IL126592A0 (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
GB9824436D0 (en) Methods of treatment
HUP0004025A3 (en) Treatment of conduct disorder using norepinephrine reuptake inhibitors
HU9803018D0 (en) Methods and compositions for the treatment and prevention of tumors, tumor-veloted disorders and cachexia
AU2003297356A8 (en) Prevention and treatment of cardiac arrhythmias
MXPA02001790A (es) Composiciones que incluyen el modafinil, para el tratamiento de desordenes en la alimentacion y para estimular el apetito.
GB0514417D0 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
PL350679A1 (en) Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
EP1229930A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALLERGIC DISORDERS
PL312079A1 (en) Derivatives of 3-phenyl isoquinolin-1 (2h)-one, method of obtaining them, therapeutic agent and pharmaceutical composition
IL133908A0 (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)
AU2003296724A8 (en) Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
WO1999057133A3 (en) Inhibitors of nf-kb activation
SI0888114T1 (en) Use of (+)-alpha-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
AU7106300A (en) Treatment of skin disorders
HUP0201966A3 (en) Methods of treatment and drug screening methods
EP1161451A4 (en) HUMAN ALPHA ENDOKIN AND METHOD FOR ITS USE

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees